Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-...

FDA Drug Recall #D-260-2013 — Class II — March 28, 2013

Recall Summary

Recall Number D-260-2013
Classification Class II — Moderate risk
Date Initiated March 28, 2013
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Pfizer Inc.
Location New York, NY
Product Type Drugs
Quantity 10121 bottles

Product Description

Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles ( NDC 60793-859-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

Reason for Recall

Chemical contamination: emission of strong odor after package was opened.

Distribution Pattern

Nationwide and PR

Lot / Code Information

Lot # a) 67507B, Exp. 02/14; b) 67508B, Exp. 02/14

Other Recalls from Pfizer Inc.

Recall # Classification Product Date
D-0544-2025 Class II Bicillin L-A (penicllin G benzathine injectable... Jul 10, 2025
D-0545-2025 Class II Bicillin L-A (penicillin G benzathine injectabl... Jul 10, 2025
D-0489-2025 Class II DOBUTamine Injection, USP, 250 mg/20 mL (12.5 m... May 28, 2025
D-0565-2024 Class II Labetalol Hydrochloride Injection, USP, 20 mg/4... May 20, 2024
D-0564-2024 Class II Buprenorphine Hydrochloride Injection, 0.3 mg b... May 20, 2024

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.